Tags

Results for Translational biology, medicine, and health graduate program

Rss Feed

- - VTCRI scientist earns third concurrent grant from the National Cancer Institute to study breast cancer
    Deb Kelly, who is also an associate professor of biological sciences in the College of Science at Virginia Tech, is working to better detect, prevent, and repair the mutations found in cancers related to the breast cancer susceptibility protein, BRCA1.
- - VTCRI scientist awarded $2 million grant to study immune memory response
    The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded a new five-year grant to Ken Oestreich, an assistant professor at the Virginia Tech Carilion Research Institute, to study immunological memory.
- - VTCRI scientists, Carilion clinicians first to identify perinexus in human heart
    The research team was led by Steven Poelzing, an associate professor at the Virginia Tech Carilion Research Institute, and Soufian AlMahameed, who was a clinician associate professor at the Virginia Tech Carilion School of Medicine and the director of Carilion Clinic’s Center for Atrial Fibrillation at the time of data collection.
- - VTCRI scientists identify novel cellular mechanism that can lead to cancer metastasis
    Scientists at the Virginia Tech Carilion Research Institute have added a new dimension to the understanding of how cells alter their communication with one another during development, wound healing, and the spread of cancer.
- - National expert on the behavioral science of scarcity to speak at VTCRI
    Eldar Shafir will discuss the complex psychology of poverty and the tradeoffs people must make when resources are scarce on May 17 at the Virginia Tech Carilion Research Institute.
- - First students earn degrees through innovative translational biology, medicine, and health program
    The program is based on the Virginia Tech Carilion Health Sciences and Technology Campus in Roanoke, and it positions students to conduct research in more than 50 departments and institutes across Virginia Tech.
- - Compounds found in grapes, dark chocolate, coffee, and blueberries can be used to treat depression
    The finding — from a study published by a Virginia Tech researcher — does not mean that people who suffer from depression should eat a bar of dark chocolate or drink a bottle of red wine as self-treatment.
- - President of nation’s largest health and science public education and advocacy organization to speak at VTCRI
    Mary Woolley, president and chief executive officer of Research!America, will speak at the Virginia Tech Carilion Research Institute on April 5.
- - VTCRI scientist awarded $2 million National Cancer Institute grant to study breast cancer
    The National Cancer Institute of the National Institutes of Health has awarded Deborah Kelly, an associate professor at the Virginia Tech Carilion Research Institute, $2 million to study the mutated form of the breast cancer susceptibility protein that is implicated in hereditary breast cancer.
- - Scientists gain insight into the earliest changes that impair motor function during aging
    A team of biomedical scientists has found that motor neurons responsible for controlling muscle movement do not age. Rather, it's the synaptic inputs connected to the motor neurons that age and cause bodily decay.
- - National expert on cognitive control to deliver VTCRI Distinguished Public Lecture
    Jonathan Cohen, co-director of the Princeton Neuroscience Institute at Princeton University, will discuss the limitations of human focus during his presentation, “On the Rational Boundedness of Cognitive Control,” at 5:30 p.m. on March 22 at the Virginia Tech Carilion Research Institute.
- - Researchers discover molecular mechanism of hereditary, tumor-causing disease
    Von Hippel-Lindau syndrome is a rare disease, affecting about one in every 36,000 people, according to the National Institutes of Health. People with the disorder have an increased risk for developing cancer, but a main concern is on the syndrome’s characteristic benign growths.
- - VTCRI to host sixth annual Brain School, other Brain Awareness Week activities
    Virginia Tech Carilion Research Institute’s sixth annual Brain School, Hijacking and Augmenting the Brain: Drugs, Bugs, and Devices, will focus on how outside factors can influence the brain’s chemistry and decision-making capacity and how the brain can interface with the outside world through digital devices.
- - Nation's leader on diabetes and obesity prevention to speak at VTCRI
    Griffin P. Rodgers will focus his talk on the Diabetes Prevention Program, a multicenter research study conducted by the National Institutes of Health.
- - VTCRI scientists identify new target for developing precision treatment in malignant brain tumors
    Currently, no standard of care exists to prevent or treat recurrent malignant primary brain tumors in patients.
- - TBMH graduate students land elusive National Institutes of Health fellowships
    Doctoral students Tristan Raisch and Carissa James have won National Institutes of Health research fellowships aimed at protecting people with heart problems.
- - Research at VTCRI reveals biological mechanism of a leading cause of childhood blindness
    The discovery in a rodent model may provide insight into what happens in the visual systems of children born with a condition that prevents the optic nerve from fully developing. The condition is also associated with autism spectrum disorder.
- - HBCU alumni at Virginia Tech share perspectives with current HBCU students at research summit
    Students from 17 historically black colleges and universities and minority serving institutions across the mid-Atlantic and South converged on Virginia Tech on a recent weekend to explore research and advanced degree opportunities.
- - Governor, Virginia Tech Carilion officials break ground on VTC Biomedical Research Expansion
    The 139,000-gross-square-foot building will rise on the Virginia Tech Carilion Health Sciences and Technology Campus at Jefferson Street and Reserve Avenue and will be physically connected by an elevated walkway to the Virginia Tech Carilion School of Medicine and Research Institute. It is expected to open in 2020.
- - Scientists identify potential key to therapeutic treatments for autoimmune diseases
    A collaborative team of scientists led by Kenneth Oestreich, an assistant professor at the Virginia Tech Carilion Research Institute, has identified a novel combination of immune response factors involved in the body’s fight against invading pathogens.

Page 1 of 3 | 57 Results